Sino Biopharmaceutical Limited (FRA:SMZ1)

Sino Biopharmaceutical Revenue

Sino Biopharmaceutical had revenue of 17.57B CNY in the half year ending June 30, 2025, with 23.04% growth. This brings the company's revenue in the last twelve months to 30.57B, up 13.23% year-over-year. In the year 2024, Sino Biopharmaceutical had annual revenue of 28.87B with 10.18% growth.

• Revenue (ttm): 30.57B CNY
• Revenue Growth: +13.23%
• P/S Ratio: 3.82
• Revenue / Employee: 1.25M CNY
• Employees: 24,379
• Market Cap: 13.87B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.87B	2.67B	10.18%
Dec 31, 2023	26.20B	173.25M	0.67%
Dec 31, 2022	26.03B	-835.19M	-3.11%
Dec 31, 2021	26.86B	3.21B	13.59%
Dec 31, 2020	23.65B	-586.81M	-2.42%